Expeditious neutralization assay for human metapneumovirus based on a recombinant virus expressing Renilla luciferase

Journal of Clinical Virology

Volumn 56, Issue 1, 2013, Pages 31-36

  Zhou, Min ^a   Kitagawa, Yoshinori ^a   Yamaguchi, Mayu ^a   Uchiyama, Chika ^a   Itoh, Masae ^b   Gotoh, Bin ^a  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b NAGAHAMA INSTITUTE OF BIO SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

Human metapneumovirus; Neutralization assay; Renilla luciferase

Indexed keywords

GREEN FLUORESCENT PROTEIN; NEUTRALIZING ANTIBODY; RENILLA LUCIFERIN 2 MONOOXYGENASE; TRYPSIN;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DILUTION; ENZYME ACTIVITY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN METAPNEUMOVIRUS; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INCUBATION TEMPERATURE; INCUBATION TIME; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE GENETICS; VIROGENESIS; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; HUMANS; LUCIFERASES; METAPNEUMOVIRUS; NEUTRALIZATION TESTS;

EID: 84871514345     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.09.014     Document Type: Article

References (22)

1. Boivin G., Abed Y., Pelletier G., Ruel L., Moisan D., Cote S., et al. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J Infect Dis 2002, 186:1330-1334.
2. van den Hoogen B.G., de Jong J.C., Groen J., Kuiken T., de Groot R., Fouchier R.A., et al. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat Med 2001, 7:719-724.
3. Crowe J.E., Williams J.V. Metapneumoviruses. The biology of pramyxoviruses 2011, 411-434. Caister Academic Press, Norfolk, UK. S.K. Samal (Ed.).
4. Viazov S., Ratjen F., Scheidhauer R., Fiedler M., Roggendorf M. High prevalence of human metapneumovirus infection in young children and genetic heterogeneity of the viral isolates. J Clin Microbiol 2003, 41:3043-3045.
5. Konig B., Konig W., Arnold R., Werchau H., Ihorst G., Forster J. Prospective study of human metapneumovirus infection in children less than 3 years of age. J Clin Microbiol 2004, 42:4632-4635.
6. Collins P.L. Human respiratory syncytial virus. The biology of paramyxoviruses 2011, 341-410. Caister Academic Press, Norfolk, UK. S.K. Samal (Ed.).
7. Glezen W.P., Paredes A., Allison J.E., Taber L.H., Frank A.L. Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level. J Pediatr 1981, 98:708-715.
8. MacPhail M., Schickli J.H., Tang R.S., Kaur J., Robinson C., Fouchier R.A., et al. Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J Gen Virol 2004, 85:1655-1663.
9. Skiadopoulos M.H., Biacchesi S., Buchholz U.J., Riggs J.M., Surman S.R., Amaro-Carambot E., et al. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness. J Virol 2004, 78:6927-6937.
10. Wyde P.R., Chetty S.N., Jewell A.M., Boivin G., Piedra P.A. Comparison of the inhibition of human metapneumovirus and respiratory syncytial virus by ribavirin and immune serum globulin in vitro. Antiviral Res 2003, 60:51-59.
11. Schickli J.H., Kaur J., Ulbrandt N., Spaete R.R., Tang R.S. An S101P substitution in the putative cleavage motif of the human metapneumovirus fusion protein is a major determinant for trypsin-independent growth in Vero cells and does not alter tissue tropism in hamsters. J Virol 2005, 79:10678-10689.
12. Biacchesi S., Skiadopoulos M.H., Yang L., Murphy B.R., Collins P.L., Buchholz U.J. Rapid human metapneumovirus microneutralization assay based on green fluorescent protein expression. J Virol Methods 2005, 128:192-197.
13. de Graaf M., Herfst S., Schrauwen E.J., van den Hoogen B.G., Osterhaus A.D., Fouchier R.A. An improved plaque reduction virus neutralization assay for human metapneumovirus. J Virol Methods 2007, 143:169-174.
14. Falsey A.R., Formica M.A., Walsh E.E. Microneutralization assay for the measurement of neutralizing antibodies to human metapneumovirus. J Clin Virol 2009, 46:314-317.
15. Kitagawa Y., Tani H., Limn C.K., Matsunaga T.M., Moriishi K., Matsuura Y. Ligand-directed gene targeting to mammalian cells by pseudotype baculoviruses. J Virol 2005, 79:3639-3652.
16. Gotoh B., Takeuchi K., Komatsu T., Yokoo J. The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling. J Virol 2003, 77:3360-3370.
17. Kitagawa Y., Zhou M., Yamaguchi M., Komatsu T., Takeuchi K., Itoh M., et al. Human metapneumovirus M2-2 protein inhibits viral transcription and replication. Microbes Infect 2010, 12:135-145.
18. Biacchesi S., Skiadopoulos M.H., Tran K.C., Murphy B.R., Collins P.L., Buchholz U.J. Recovery of human metapneumovirus from cDNA: optimization of growth in vitro and expression of additional genes. Virology 2004, 321:247-259.
19. Herfst S., de Graaf M., Schickli J.H., Tang R.S., Kaur J., Yang C.F., et al. Recovery of human metapneumovirus genetic lineages A and B from cloned cDNA. J Virol 2004, 78:8264-8270.
20. Takeda M., Ohno S., Seki F., Nakatsu Y., Tahara M., Yanagi Y. Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol 2005, 79:14346-14354.
21. Niwa H., Yamamura K., Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene 1991, 108:193-199.
22. Kitagawa Y., Yamaguchi M., Zhou M., Komatsu T., Nishio M., Sugiyama T., et al. A tryptophan-rich motif in the human parainfluenza virus type 2 V protein is critical for the blockade of toll-like receptor 7 (TLR7)- and TLR9-dependent signaling. J Virol 2011, 85:4606-4611.